CIK 0001645469
- Non-accelerated filer
- Smaller reporting company
Monopar Therapeutics
Sign in to watch- Ticker
- MNPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320463781
- Phone
- +1 847-388-0349
- Business address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,335,315
- in 9 filings, $5.3M under 10b5-1 plans
Net −$5,335,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-31 | Robinson Chandler Chief Executive Officer | Shares withheld for taxes | −1,364 | $3.21 | $4K | 29,335.8 |
| 2021-12-31 | Robinson Chandler Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −3,941 | 47,295 | ||
| 2021-12-31 | Anderson Raymond Director | Exercise or conversion | +751 | 5,294 | ||
| 2021-12-31 | Anderson Raymond Director | Exercise or conversion · Restricted Stock Units | −751 | 0 | ||
| 2021-12-31 | Brown Michael J Director | Exercise or conversion | +751 | 214,294 | ||
| 2021-12-31 | Brown Michael J Director | Exercise or conversion · Restricted Stock Units | −751 | 0 | ||
| 2021-12-31 | STARR CHRISTOPHER M Director | Exercise or conversion | +751 | 4,294 | ||
| 2021-12-31 | STARR CHRISTOPHER M Director | Exercise or conversion · Restricted Stock Units | −751 | 0 | ||
| 2021-12-31 | KLAUSNER ARTHUR J Director | Exercise or conversion | +751 | 9,294 | ||
| 2021-12-31 | KLAUSNER ARTHUR J Director | Exercise or conversion · Restricted Stock Units | −751 | 0 | ||
| 2021-09-30 | Mazar Andrew Paul Chief Scientific Officer | Exercise or conversion | +1,606 | 19,144.8 | ||
| 2021-09-30 | Mazar Andrew Paul Chief Scientific Officer | Shares withheld for taxes | −471 | $4.87 | $2K | 18,673.8 |
| 2021-09-30 | Mazar Andrew Paul Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −1,606 | 20,879 | ||
| 2021-09-30 | Tsuchimoto Kim R Chief Financial Officer | Exercise or conversion | +1,221 | 3,892 | ||
| 2021-09-30 | Tsuchimoto Kim R Chief Financial Officer | Shares withheld for taxes | −423 | $4.87 | $2K | 3,469 |
| 2021-09-30 | Tsuchimoto Kim R Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −1,221 | 15,873 | ||
| 2021-09-30 | STARR CHRISTOPHER M Director | Exercise or conversion | +751 | 3,543 | ||
| 2021-09-30 | STARR CHRISTOPHER M Director | Exercise or conversion · Restricted Stock Units | −751 | 751 | ||
| 2021-09-30 | Anderson Raymond Director | Exercise or conversion | +751 | 4,543 | ||
| 2021-09-30 | Anderson Raymond Director | Exercise or conversion · Restricted Stock Units | −751 | 751 |
Page 21 of 28 · 549 trades